We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 14, 2022

Concomitant Use of Diltiazem With DOACs and Bleeding Risk in Atrial Fibrillation

Journal of the American Heart Association

 

Additional Info

Journal of the American Heart Association
Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
J Am Heart Assoc 2022 Jul 05;[EPub Ahead of Print], Y Xu, AR Chang, LA Inker, et al

Further Reading